{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:28:37Z","timestamp":1768285717014,"version":"3.49.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0136046","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T17:52:57Z","timestamp":1441993977000},"page":"e0136046","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":72,"title":["CRISPR\/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection"],"prefix":"10.1371","volume":"10","author":[{"given":"Hassen S.","family":"Wollebo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bellizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyn K.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,9,11]]},"reference":[{"issue":"Suppl2","key":"ref1","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3949\/ccjm.78.s2.03","article-title":"The clinical features of PML","volume":"78","author":"JR Berger","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"ref2","first-page":"93","article-title":"Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease","volume":"81","author":"KE \u00c5str\u00f6m","year":"1958","journal-title":"Brain"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/rmv.710","article-title":"Progressive multifocal leukoencephalopathy: clinical and molecular aspects","volume":"22","author":"E Tavazzi","year":"2012","journal-title":"Rev Med Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11910-013-0408-6","article-title":"Progressive multifocal leukoencephalopathy in multiple sclerosis","volume":"13","author":"JJ Chalkley","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1212\/WNL.0b013e3182478d4b","article-title":"Fatal progressive multifocal leukoencephalopathy associated with efalizumab therapy: insights into the role of leukointegrin aLb2 in JC virus control","volume":"78","author":"N Schwab","year":"2012","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","article-title":"Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis","volume":"68","author":"DB Clifford","year":"2011","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.clineuro.2012.11.016","article-title":"Progressive multifocal leukoencephalopathy developed 26 years after renal transplantation","volume":"115","author":"S Nagayama","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"ref8","first-page":"1633","article-title":"Fields Virology","author":"JA DeCaprio","year":"2013"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.20266","article-title":"The agnoprotein of polyomaviruses: a multifunctional auxiliary protein","volume":"204","author":"K Khalili","year":"2005","journal-title":"J Cell Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/jiq097","article-title":"Pathogenesis of progressive multifocal leukoencephalopathy\u2014revisited","volume":"203","author":"MK White","year":"2011","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","article-title":"The human polyomavirus, JCV, uses serotonin receptors to infect cells","volume":"306","author":"GF Elphick","year":"2004","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/13550280802235916","article-title":"Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells","volume":"14","author":"ML Chapagain","year":"2008","journal-title":"J Neurovirol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/AAC.41.3.587","article-title":"Activities of various compounds against murine and primate polyomaviruses","volume":"41","author":"G Andrei","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/13550289809114545","article-title":"The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line","volume":"4","author":"J Hou","year":"1998","journal-title":"J. Neurovirol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"T Gaj","year":"2013","journal-title":"Trends Biotechnol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nmeth.2649","article-title":"Cas9 as a versatile tool for engineering biology","volume":"10","author":"P Mali","year":"2013","journal-title":"Nat Methods"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"JA Doudna","year":"2014","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"PD Hsu","year":"2014","journal-title":"Cell"},{"key":"ref19","article-title":"Genome editing strategies: potential tools for eradicating HIV-1\/AIDS","author":"K Khalili","year":"2015","journal-title":"J Neurovirol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-genet-110410-132430","article-title":"CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation","volume":"45","author":"D Bhaya","year":"2011","journal-title":"Annu Rev Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells using a bacterial CRISPR\/Cas RNA-guided endonuclease","volume":"88","author":"EM Kennedy","year":"2014","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo","volume":"3","author":"SR Lin","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection","volume":"111","author":"W Hu","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1038\/sj.onc.1209618","article-title":"Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses","volume":"25","author":"MK White","year":"2006","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2004.03.025","article-title":"Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis","volume":"324","author":"MK White","year":"2004","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2010.11.013","article-title":"Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy","volume":"233","author":"HS Wollebo","year":"2011","journal-title":"J Neuroimmunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1073\/pnas.82.4.1257","article-title":"Establishment of a line of human fetal glial cells that supports JC virus multiplication","volume":"82","author":"EO Major","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3892\/ijo.7.4.801","article-title":"Characterization of glioma cells derived from human polyomavirus-induced brain tumors in hamsters","volume":"7","author":"G Raj","year":"1995","journal-title":"Int J Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/viro.2000.0450","article-title":"Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma","volume":"274","author":"B Krynska","year":"2000","journal-title":"Virology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"L Cong","year":"2013","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/JVI.70.6.4150-4156.1996","article-title":"Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha","volume":"70","author":"CF Chang","year":"1996","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virol.2012.06.010","article-title":"Cooperative Roles of NF-\u03baB and NFAT4 in polyomavirus JC regulation at the KB control element","volume":"432","author":"HS Wollebo","year":"2012","journal-title":"Virology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1128\/JVI.77.19.10638-10644.2003","article-title":"JC virus-induced changes in cellular gene expression in primary human astrocytes","volume":"77","author":"S Radhakrishnan","year":"2003","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1128\/JVI.78.13.7264-7269.2004","article-title":"Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection","volume":"78","author":"S Radhakrishnan","year":"2004","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0042-6822(73)90341-3","article-title":"A new technique for the assay of infectivity of human adenovirus 5 DNA","volume":"52","author":"FL Graham","year":"1973","journal-title":"Virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-62703-640-5_12","article-title":"Lentiviral transduction of neuronal cells","volume":"1078","author":"HS Wollebo","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/JVI.51.2.458-469.1984","article-title":"Human polyomavirus JC virus genome","volume":"51","author":"RJ Frisque","year":"1984","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0042-6822(89)90381-4","article-title":"Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins","volume":"170","author":"MS Lashgari","year":"1989","journal-title":"Virology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00018-009-8631-7","article-title":"The regulation of cell proliferation by the papillomavirus early proteins","volume":"66","author":"NA Hamid","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"ref40","first-page":"612823","article-title":"Disruption of HPV16-E7 by CRISPR\/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells","volume":"2014","author":"Z Hu","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbrc.2014.07.014","article-title":"In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR\/Cas9","volume":"450","author":"S Zhen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/JVI.14.2.384-391.1974","article-title":"DNA of a human hepatitis B virus candidate","volume":"14","author":"WS Robinson","year":"1974","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting Hepatitis B Virus with CRISPR\/Cas9","volume":"3","author":"C Seeger","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","article-title":"Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease","volume":"476","author":"EM Kennedy","year":"2015","journal-title":"Virology"},{"key":"ref45","article-title":"Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus","author":"S Zhen","year":"2015","journal-title":"Gene Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1525-1381.1999.t01-1-99220.x","article-title":"Epstein-Barr virus: the first human tumor virus and its role in cancer","volume":"111","author":"JS Pagano","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1073\/pnas.1410785111","article-title":"RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection","volume":"111","author":"J Wang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1099\/jgv.0.000012","article-title":"CRISPR\/Cas9-mediated genome editing of Epstein-Barr virus in human cells","volume":"96","author":"KS Yuen","year":"2015","journal-title":"J Gen Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"H Ebina","year":"2013","journal-title":"Sci Rep"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/ncomms7413","article-title":"Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells","volume":"6","author":"HK Liao","year":"2015","journal-title":"Nat Commun"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","article-title":"The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA","volume":"12","author":"W Zhu","year":"2015","journal-title":"Retrovirology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/CMR.00124-13","article-title":"Viruses and human cancers: a long road of discovery of molecular paradigms","volume":"27","author":"MK White","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1128\/JVI.72.10.8150-8157.1998","article-title":"Development of a self-inactivating lentivirus vector","volume":"72","author":"H Miyoshi","year":"1998","journal-title":"J Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"R Zufferey","year":"1998","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156652307780859062","article-title":"Current advances and future challenges in Adenoviral vector biology and targeting","volume":"7","author":"SK Campos","year":"2007","journal-title":"Curr Gene Ther"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"S Daya","year":"2008","journal-title":"Clin Microbiol Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0136046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T18:07:41Z","timestamp":1653156461000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0136046"}},"subtitle":[],"editor":[{"given":"Luwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,11]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0136046","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,11]]}}}